Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 ...

After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told ...

GeneDx Holdings WGS recently announced a strategic partnership with Komodo Health that is likely to combine its Infinity ...

Chief Executive Officer Bob Bradway told attendees at a J.P. Morgan-hosted event that the company views 2026 as a “springboard year,” driven in part by what he described as a significant amount of ...

Under Robert F. Kennedy Jr.’s guidance, the CDC no longer recommends routine vaccination to protect against meningococcal ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company” or "Solid”), a life sciences company developing precision genetic ...

India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...

After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...

Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient ...

The Bay Area has now recorded two measles cases since late last year — an early test of whether one of the nation’s most ...

More than 2,140 measles cases were confirmed nationwide last year — the highest total in decades. California accounted for ...

U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat in sickle cell disease anticipated in first quarter of 2026, with planned U.S ...